Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor Agonists”

143 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 143 results

Not applicableUnknownNCT05492305
What this trial is testing

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Who this might be right for
Diabetes MellitusObesityMental Health Issue
King's College London 20
Not applicableLooking for participantsNCT07027995
What this trial is testing

Food and Fitness With Medicine (FFWM)

Who this might be right for
Cardiovascular Kidney Metabolic SyndromeType 2 Diabetes
Ohio State University 200
Not applicableNot Yet RecruitingNCT07701460
What this trial is testing

Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1

Who this might be right for
Weight Maintenance
Tufts University 200
Not applicableUnknownNCT05990374
What this trial is testing

Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

Who this might be right for
Diabetes
Nanjing First Hospital, Nanjing Medical University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314528
What this trial is testing

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)+2 more
St. James's Hospital, Ireland 42
Not applicableEnded earlyNCT07190794
What this trial is testing

RESCUE: Discontinuation of GLP-1

Who this might be right for
Obesity
Boston Scientific Corporation 18
Testing effectiveness (Phase 2)Study completedNCT07610174
What this trial is testing

Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves

Who this might be right for
Heart FailureHeart Valve Prosthesis
Kafrelsheikh University 160
Large-scale testing (Phase 3)Looking for participantsNCT07193459
What this trial is testing

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 360
Not applicableStudy completedNCT06017544
What this trial is testing

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2Myocardial Infarction
University of Campania Luigi Vanvitelli 257
Not applicableNot Yet RecruitingNCT07014709
What this trial is testing

Impact of GLP-1 Receptor Agonists on Patients With IPMN

Who this might be right for
IPMNIPMN, PancreaticGLP-1+2 more
Hôpital Fribourgeois 30
Testing effectiveness (Phase 2)UnknownNCT06500299
What this trial is testing

Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

Who this might be right for
Overweight and Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 180
Large-scale testing (Phase 3)Looking for participantsNCT06825182
What this trial is testing

Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Nanjing First Hospital, Nanjing Medical University 1,000
Not applicableStudy completedNCT06608433
What this trial is testing

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Who this might be right for
Healthy Volunteer StudyHPACortisol Deficiency+1 more
University Hospital, Basel, Switzerland 22
Large-scale testing (Phase 3)Active Not RecruitingNCT06162715
What this trial is testing

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial

Who this might be right for
Severe ObesityObesityBMI Greater Than 30
Vanderbilt University Medical Center 30
Very early researchLooking for participantsNCT07012642
What this trial is testing

Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

Who this might be right for
Lymphedema
Advanced Reconstructive Surgery Alliance 110
Testing effectiveness (Phase 2)Looking for participantsNCT07336862
What this trial is testing

Bariatric Surgery Combined With GLP-1 Receptor Agonists Study

Who this might be right for
Obesity
China-Japan Friendship Hospital 200
Not applicableLooking for participantsNCT07732426
What this trial is testing

Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies

Who this might be right for
Food Addiction TendencyObesityOverweight
Seoul National University Hospital 30
Not applicableUnknownNCT06344247
What this trial is testing

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Who this might be right for
ObesityChronic Kidney Diseases
RenJi Hospital 48
Not applicableLooking for participantsNCT07789223
What this trial is testing

Weight and Metabolic Management Study

Who this might be right for
OverweightObesityWeight Maintenance
Elenzia 200
Post-approval studies (Phase 4)UnknownNCT02501850
What this trial is testing

The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)

Who this might be right for
Diabetes Mellitus Type 2
Hospital Universitari Vall d'Hebron Research Institute 40
Next Page